Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy

Full text
Author(s):
Chevillard, Christophe [1] ; Nunes, Joao Paulo Silva [2, 3, 4] ; Frade, Amanda Farage [3, 4, 5] ; Almeida, Rafael Ribeiro [2, 3, 4] ; Pandey, Ramendra Pati [2, 3, 4] ; Nascimento, Marilda Savoia [2, 3, 4] ; Kalil, Jorge [2, 3, 4] ; Cunha-Neto, Edecio [2, 3, 4]
Total Authors: 8
Affiliation:
[1] Aix Marseille Univ, INSERM UMR 1090, TAGC, Marseille - France
[2] Univ Sao Paulo, Fac Med, Disciplina Imunol Clin & Alergia, Sao Paulo - Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Lab Imunol, Inst Coracao, Sao Paulo - Brazil
[4] INCT, Inst Invest Immunol III, Sao Paulo - Brazil
[5] Brazil Univ, Dept Bioengn, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: FRONTIERS IN IMMUNOLOGY; v. 9, DEC 3 2018.
Web of Science Citations: 3
Abstract

Chagas disease is caused by infection with the protozoan Trypanosoma cruzi and affects over 8 million people worldwide. In spite of a powerful innate and adaptive immune response in acute infection, the parasite evades eradication, leading to a chronic persistent infection with low parasitism. Chronically infected subjects display differential patterns of disease progression. While 30% develop chronic Chagas disease cardiomyopathy (CCC)-a severe inflammatory dilated cardiomyopathy-decades after infection, 60% of the patients remain disease-free, in the asymptomatic/indeterminate (ASY) form, and 10% develop gastrointestinal disease. Infection of genetically deficient mice provided a map of genes relevant for resistance to T. cruzi infection, leading to the identification of multiple genes linked to survival to infection. These include pathogen resistance genes (PRG) needed for intracellular parasite destruction, and genes involved in disease tolerance (protection against tissue damage and acute phase death-DTG). All identified DTGs were found to directly or indirectly inhibit IFN-gamma production or Th1 differentiation. We hypothesize that the absolute need for DTG to control potentially lethal IFN-gamma PRG activity leads to T. cruzi persistence and establishment of chronic infection. IFN-gamma production is higher in CCC than ASY patients, and is the most highly expressed cytokine in CCC hearts. Key DTGs that downmodulate IFN-gamma, like IL-10, and Ebi3/IL27p28, are higher in ASY patients. Polymorphisms in PRG and DTG are associated with differential disease progression. We thus hypothesize that ASY patients are disease tolerant, while an imbalance of DTG and IFN-gamma PRG activity leads to the inflammatory heart damage of CCC. (AU)

FAPESP's process: 14/50890-5 - INCT of Investigation in Immunology
Grantee:Jorge Elias Kalil Filho
Support type: Research Projects - Thematic Grants
FAPESP's process: 16/15209-0 - New therapies for Chagas Disease: repurposing of drugs acting on the invasion of host cells by T. cruzi, and potentiation of benznidazole effect in resistant strains and in the hamster model of chronic chagas disease cardiomyopathy
Grantee:Edecio Cunha Neto
Support type: Research Grants - Research in Public Policies for the National Health Care System (PP-SUS)
FAPESP's process: 13/50302-3 - Identification of predictive / prognostic genetic signature in Chagas cardiomyopathy: a systems biology approach
Grantee:Edecio Cunha Neto
Support type: Regular Research Grants